Stress-activated Protein Kinases and Chemotherapy
Stress-activated Protein Kinases and Chemotherapy
批准号:
6541824
负责人:
TIMOTHY C. CHAMBERS
金额:
$20.25万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-04-01 至 2006-08-31
关键词:
AP1 protein JUN kinase antimitotics antineoplastics apoptosis biological signal transduction cysteine endopeptidases cytotoxicity enzyme inhibitors gene expression immunocytochemistry immunoprecipitation neoplasm /cancer chemotherapy oligonucleotides pharmacokinetics phosphorylation protooncogene tissue /cell culture transcription factor transfection vinblastine western blottings
中文摘要
描述(由申请人提供):抗癌药物与其主要靶点的相互作用仅代表药物作用机制的第一步。如果要在提高这些药物的有效性方面取得进展,了解随后诱导的凋亡信号机制至关重要。我们研究的总体目标是通过了解这些凋亡信号通路的性质和调控来改善癌症化疗。具体来说,我们感兴趣的是确定应激激活的c-Jun nh2末端蛋白激酶(JNK)在抗有丝分裂抗癌药物(特别是长春花碱)的作用机制中的作用。在Specific Aim 1中,我们将特异性抑制JNK对c-Jun/AP-1的信号传导,并研究AP-1抑制对长春花碱诱导的细胞凋亡和基因表达的影响,以确定推测的AP-1靶基因。Specific Aim 2将采用分子和细胞相结合的方法,测试相关AP-1靶基因在长春花碱诱导的细胞凋亡中的中介作用。这一目标的完成将为所鉴定的候选基因的作用提供实验验证,并更好地理解vinblastine激活的JNK/AP-1的凋亡信号传导机制。特异性Aim 3将利用染色质免疫沉淀来证明c-Jun在相关AP-1靶基因的调控区域的招募,并确定可能与c-Jun合作的新的调控伙伴。Specific Aim 4将利用c-Jun -/-永生化成纤维细胞作为一个独特的模型系统,进一步探索c-Jun在长春花碱细胞应答中的作用。本研究将为JNKJc-Jun在长春花碱诱导的细胞凋亡中的作用提供分子视角,有助于我们对JNKJc-Jun及相关药物的作用机制有基本的认识。反过来,这项研究可能提出新的方法来改变细胞死亡的阈值,使这些药物更有效,减少毒性和提高特异性。
英文摘要
DESCRIPTION (provided by applicant): The interaction of an anticancer agent with its primary target represents only the first step in the drug's mechanism of action. Knowledge of the apoptotic signaling mechanisms subsequently induced is of critical importance if advances are to be made in improving the effectiveness of these agents. The overall goal of our research is to improve cancer chemotherapy by understanding the nature and regulation of these apoptotic signaling pathways. Specifically, we are interested in defining the role of the stress-activated, c-Jun NH2-terminal protein kinase (JNK) in the mechanism of action of antimitotic anticancer drugs, particularly vinblastine. In Specific Aim 1 we will specifically inhibit JNK signaling to c-Jun/AP-1 and examine the effects of AP-1 inhibition on vinblastine-induced apoptosis and on gene expression in order to identify putative AP-1 target genes. Specific Aim 2 will test the relevant AP-1 target genes as intermediates in vinblastine-induced apoptosis, using a combination of molecular and cellular approaches. Completion of this aim will provide experimental verification of the role of the candidate genes identified, and a better understanding of the mechanisms of apoptotic signaling by vinblastine-activated JNK/AP-1. Specific Aim 3 will utilize chromatin immunoprecipitation to demonstrate recruitment of c-Jun to the regulatory regions of the relevant AP-1 target genes, and to identify novel regulatory partners that may cooperate with c-Jun. Specific Aim 4 will utilizec-jun-/- immortalized fibroblasts as a unique model system to further explore the role of c-Jun in the cellular response to vinblastine. This research will provide molecular insight into the role of JNKJc-Jun in vinblastine-induced apoptosis, and contribute to our basic understanding of the mechanism of action of this and related agents. In turn, this research may suggest novel approaches to alter the threshold for cell death to make these drugs more effective, lessening toxicity and improving specificity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
BcL-2 Proteins in Mechanism of Anti-mitotic Drug Action
-
批准号:7232016
-
项目类别:
-
资助金额:$22.08万
-
财政年份:2004
-
负责人:TIMOTHY C. CHAMBERS
-
依托单位:
BcL-2 Proteins in Mechanism of Anti-mitotic Drug Action
-
批准号:6825903
-
项目类别:
-
资助金额:$25.34万
-
财政年份:2004
-
负责人:TIMOTHY C. CHAMBERS
-
依托单位:
BcL-2 Proteins in Mechanism of Anti-mitotic Drug Action
-
批准号:6911501
-
项目类别:
-
资助金额:$23.29万
-
财政年份:2004
-
负责人:TIMOTHY C. CHAMBERS
-
依托单位:
BcL-2 Proteins in Mechanism of Anti-mitotic Drug Action
-
批准号:7105497
-
项目类别:
-
资助金额:$22.74万
-
财政年份:2004
-
负责人:TIMOTHY C. CHAMBERS
-
依托单位:
BcL-2 Proteins in Mechanism of Anti-mitotic Drug Action
-
批准号:7423961
-
项目类别:
-
资助金额:$22.08万
-
财政年份:2004
-
负责人:TIMOTHY C. CHAMBERS
-
依托单位:
Bcl-2 Proteins in Mechanism of Anti-mitotic Drug Action
-
批准号:8097482
-
项目类别:
-
资助金额:$22.72万
-
财政年份:2004
-
负责人:TIMOTHY C. CHAMBERS
-
依托单位:
Bcl-2 Proteins in Mechanism of Anti-mitotic Drug Action
-
批准号:8468921
-
项目类别:
-
资助金额:$21.36万
-
财政年份:2004
-
负责人:TIMOTHY C. CHAMBERS
-
依托单位:
Bcl-2 Proteins in Mechanism of Anti-mitotic Drug Action
-
批准号:7985884
-
项目类别:
-
资助金额:$23.42万
-
财政年份:2004
-
负责人:TIMOTHY C. CHAMBERS
-
依托单位:
Bcl-2 Proteins in Mechanism of Anti-mitotic Drug Action
-
批准号:8677736
-
项目类别:
-
资助金额:$22.04万
-
财政年份:2004
-
负责人:TIMOTHY C. CHAMBERS
-
依托单位:
Bcl-2 Proteins in Mechanism of Anti-mitotic Drug Action
-
批准号:8267701
-
项目类别:
-
资助金额:$22.72万
-
财政年份:2004
-
负责人:TIMOTHY C. CHAMBERS
-
依托单位:
Prostate tumor progression by mitochondrial DNA change
-
批准号:8461704
-
项目类别:
-
资助金额:$21.88万
-
财政年份:2003
-
负责人:TIMOTHY C. CHAMBERS
-
依托单位:
STRESS ACTIVATED PROTEIN KINASES AND CHEMOTHERAPY
-
批准号:2606596
-
项目类别:
-
资助金额:$16.83万
-
财政年份:1998
-
负责人:TIMOTHY C. CHAMBERS
-
依托单位:
Stress-activated Protein Kinases and Chemotherapy
-
批准号:6943028
-
项目类别:
-
资助金额:$21.3万
-
财政年份:1998
-
负责人:TIMOTHY C. CHAMBERS
-
依托单位:
Stress-activated Protein Kinases and Chemotherapy
-
批准号:6652104
-
项目类别:
-
资助金额:$21.3万
-
财政年份:1998
-
负责人:TIMOTHY C. CHAMBERS
-
依托单位:
Stress-activated Protein Kinases and Chemotherapy
-
批准号:6799018
-
项目类别:
-
资助金额:$4.14万
-
财政年份:1998
-
负责人:TIMOTHY C. CHAMBERS
-
依托单位:
Stress-activated Protein Kinases and Chemotherapy
-
批准号:6764631
-
项目类别:
-
资助金额:$2.06万
-
财政年份:1998
-
负责人:TIMOTHY C. CHAMBERS
-
依托单位:
STRESS ACTIVATED PROTEIN KINASES AND CHEMOTHERAPY
-
批准号:6150260
-
项目类别:
-
资助金额:$16.71万
-
财政年份:1998
-
负责人:TIMOTHY C. CHAMBERS
-
依托单位:
STRESS ACTIVATED PROTEIN KINASES AND CHEMOTHERAPY
-
批准号:2871974
-
项目类别:
-
资助金额:$16.22万
-
财政年份:1998
-
负责人:TIMOTHY C. CHAMBERS
-
依托单位:
STRESS ACTIVATED PROTEIN KINASES AND CHEMOTHERAPY
-
批准号:6350246
-
项目类别:
-
资助金额:$17.21万
-
财政年份:1998
-
负责人:TIMOTHY C. CHAMBERS
-
依托单位:
Stress-activated Protein Kinases and Chemotherapy
-
批准号:6801128
-
项目类别:
-
资助金额:$21.3万
-
财政年份:1998
-
负责人:TIMOTHY C. CHAMBERS
-
依托单位:
海外基金